A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Trial of Azithromycin inPatients with CF, Chronically Infected with Pseudomonas Aeruginosa

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/009/30/02

Funding

  • Cystic Fibrosis Foundation: $23,996.00